Fitch issues warning about looming start of hospital repayments to Medicare
Hospitals could struggle to repay Medicare loans, which will come due soon, amid re-impositions of elective surgery bans.
Hospitals scramble to meet price transparency requirements after court decision
Hospitals have a lot of costly work to do to meet CMS requirements to publicly post the rates they negotiate with health plans.
COVID-19 impact on independent primary care physician practices could accelerate the shift to value based payment
Health plans are taking this opportunity to align more closely with independent PCPs, including BCBS of North Carolina, where practices’ acceptance of financial support requires them to join one of health plan’s existing ACOs.
110,000 Medicare beneficiaries were hospitalized for COVID-19 by mid-May
By mid-May, hospitals had treated 110,000 Medicare beneficiaries for COVID-19.
Possible compromise in hospital price disclosure fight
While the Trump administration prevailed in the first round of the lawsuit challenging its price transparency policy, the American Hospital Association has indicated it will appeal the ruling.
Hospital margins positive in May due to temporary federal boost, report finds
Federal assistance temporarily boosted hospital margins in May into positive territory.
HHS’s Cares Act Provider Relief Act FAQ updates provide additional guidance for healthcare providers
HFMA's Chad Mulvany reviews four updates from the U.S. Department of Health & Human Services, including quarterly reporting requirements, that could be of interest to HFMA members.
Texas Oncology streamlines operations to achieve success in Medicare value-based payment model
The experience of Texas Oncology in CMS’s Oncology Care Model shows how provider organizations can use change management processes to lay the foundation for success in new care delivery models.
Bundled payment participants face choices on 2020 performance measurement, continued participation
CMS further detailed how hospitals should evaluate their 2020 options and whether to continue in the BPCI-A model.
CMS aims to spur value-based payment arrangements between drugmakers and insurers, including Medicaid
CMS says rule changes would allow more outcomes-based payment arrangements for Medicaid programs and commercial health plans.